Panelists discuss the questions below in this video. What is the epidemiology and prognosis of desmoid tumor? Where on the body are desmoid tumors usually found? Can you please describe the ...
Desmoid tumours, also known as desmoid-type fibromatosis, represent a rare yet locally aggressive proliferation of fibroblasts. Despite their benign classification due to the lack of metastatic ...
Add Yahoo as a preferred source to see more of our stories on Google. Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s ...
Desmoid fibromatosis (DF) is a locally aggressive tumor with low mortality but significant morbidity. There is a lack of standard of care, and existing therapies are associated with significant ...
Confirmed RECIST v1.1 ORR favored varegacestat (56% vs 9%; P<.0001), with exploratory median best tumor-volume change of −83% ...
Registrational trial met primary endpoint, with varegacestat significantly improving progression-free survival vs. placebo (hazard ratio = 0.16, p<0.0001) Trial also met all key secondary endpoints, ...
The US Food and Drug Administration approved nirogacestat (Ogsiveo, SpringWorks Therapeutics, Inc) to treat progressive, unresectable, recurrent, or refractory desmoid tumors in adults. Nirogacestat, ...
Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s mother also had 28 surgeries related to her desmoid tumors and multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results